1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early predictors of prolonged unemployment after a diagnosis of breast cancer
    Meeting Abstract

    Blinder, V.; Patil, S.; Eberle, C.; Maly, R. C.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A phase II trial of ganetespib: Efficacy and safety in patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Drullinsky, P.; Sugarman, S.; Wasserheit-Leiblich, C.; Moynahan, M. E.; D'Andrea, G.; Haque, S.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics
    Meeting Abstract

    Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M. A.; Heller, G.; Giralt, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Targeted oligonucleotide array assessment of genomic copy number alterations for risk stratification in chronic lymphocytic leukemia
    Meeting Abstract

    Houldsworth, J.; Guttapalli, A.; Yan, X. J.; Ma, C.; Chen, W. Y.; Patil, S.; Rai, K. R.; Chiorazzi, N.
    Blood (2011)

    Fulltext@MSK | Save
  • Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Meeting Abstract

    Bhagwat, N.; Koppikar, P.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Mullally, A.; Abdel-Wahab, O.; Leung, L.; Weinstein, A.; Marubayashi, S.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Janus kinase-2 inhibition induces durable tolerance to alloantigen by dendritic cell-stimulated human T cells, yet preserves immunity to recall antigen
    Meeting Abstract

    Betts, B. C.; Abdel-Wahab, O.; Curran, S. A.; St Angelo, E. T.; Koppikar, P.; Heller, G.; Levine, R. L.; Young, J. W.
    Blood (2011)

    Fulltext@MSK | Save
  • Targeting tumor angiogenesis in combination with endocrine therapy in patients with hormone-receptor positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Traina, T.; Rugo, H.; Geneus, S.; Patil, S.; Hudis, C.; Dickler, M. N.
    European Journal of Clinical and Medical Oncology (2011)

    Fulltext@MSK | Save
  • Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study
    Journal Article

    Teraoka, S. N.; Bernstein, J. L.; Reiner, A. S.; Haile, R. W.; Bernstein, L.; Lynch, C. F.; Malone, K. E.; Stovall, M.; Capanu, M.; Liang, X.; more...
    Breast Cancer Research (2011)

    Fulltext@MSK | Save
  • A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma
    Journal Article

    Shah, M. A.; Power, D. G.; Kindler, H. L.; Holen, K. D.; Kemeny, M. M.; Ilson, D. H.; Tang, L.; Capanu, M.; Wright, J. J.; Kelsen, D. P.
    Investigational New Drugs (2011)

    Fulltext@MSK | Save
  • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
    Clinical Breast Cancer (2011)

    Fulltext@MSK | Save